Ziopharm oncology inc (ZIOP)
Balance Sheet / Yearly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10Sep'10Dec'09
ASSETS
Current assets:
Cash and cash equivalents

171,000

79,741

88,419

43,563

51,487

61,729

31,728

40,404

51,108

70,946

84,406

97,194

66,447

81,053

94,683

109,004

124,846

140,717

163,843

118,550

129,684

42,803

46,122

53,001

60,385

68,204

23,631

38,932

55,655

73,306

95,333

110,391

128,008

104,713

118,933

130,282

60,392

66,471

48,839

Receivables

782

3,330

3,441

1,460

854

1,864

1,021

663

18

19

13

44

67

21

25

15

1,060

446

369

89

62

145

208

32

27

145

449

31

72

58

13

-

-

79

79

-

-

-

-

Prepaid expenses and other current assets

19,836

22,421

23,739

20,836

21,752

20,692

14,412

11,926

20,989

19,818

30,469

27,892

26,236

23,810

20,969

17,690

14,483

11,358

8,268

4,441

857

1,139

1,484

991

1,589

1,948

3,195

4,067

4,834

6,912

7,235

9,051

10,803

1,313

1,405

1,016

424

352

354

Total current assets

191,620

105,492

115,599

65,859

74,093

84,285

47,161

52,993

72,115

90,783

114,888

125,130

92,750

104,884

115,677

126,709

140,389

152,521

172,480

123,080

130,603

44,087

47,814

54,024

62,001

70,297

27,275

43,030

60,561

80,276

102,581

119,442

138,811

106,105

120,417

131,298

60,816

66,823

49,193

Property and equipment, net

3,784

1,110

828

877

967

1,097

1,344

1,332

1,244

1,211

1,047

1,062

1,124

843

825

682

667

581

262

321

426

531

654

683

679

801

1,336

1,713

1,909

1,994

2,108

1,982

1,177

1,141

886

549

253

230

255

Right of use asset

2,079

2,272

1,283

1,438

1,589

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deposits

130

130

130

130

130

128

128

128

128

128

128

128

128

128

128

128

128

128

128

128

128

128

128

128

128

128

128

128

133

133

133

132

91

91

91

91

87

87

46

Other non-current assets

666

110

109

4,869

6,724

9,541

18,168

21,930

13,974

13,484

496

493

492

493

492

493

498

494

491

509

491

491

513

513

517

528

739

732

743

1,001

818

824

794

771

882

883

364

310

242

Total assets

198,279

109,114

117,949

73,173

83,503

95,051

66,801

76,383

87,461

105,606

116,559

126,813

94,494

106,348

117,122

128,012

141,682

153,724

173,361

124,038

131,648

45,237

49,109

55,348

63,325

71,754

29,478

45,603

63,346

83,404

105,640

122,380

140,873

108,108

122,276

132,821

61,520

67,450

49,736

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable

396

906

926

941

859

707

1,269

588

606

4,417

1,524

81

226

156

1,814

2,031

1,908

2,008

4,154

3,143

779

2,004

1,953

447

578

422

891

1,165

983

1,509

4,248

1,470

1,984

1,727

2,160

1,784

1,031

1,088

1,789

Accrued expenses

15,355

10,846

9,573

8,799

6,836

8,763

9,377

8,663

8,878

9,909

10,110

9,354

10,687

9,109

7,364

7,392

8,582

8,906

18,138

8,752

8,220

7,182

7,803

7,773

5,752

6,357

11,573

18,969

18,521

16,516

16,682

15,502

11,534

10,821

8,789

6,084

2,538

2,978

1,261

Lease liability - current portion

828

774

677

660

644

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue - current portion

-

-

-

-

-

-

49,513

-

476

6,389

6,389

6,389

6,389

6,389

6,389

6,389

6,489

6,861

6,933

816

1,088

1,360

1,700

2,333

800

800

800

800

800

800

800

800

800

800

800

800

-

-

-

Deferred rent - current portion

-

-

-

-

-

13

24

63

102

141

166

164

162

155

177

223

295

348

402

399

405

280

244

235

224

212

98

63

58

39

6

4

12

15

21

23

43

40

45

Total current liabilities

16,579

12,526

11,176

10,400

8,339

9,483

60,183

9,314

10,062

20,856

18,189

15,988

17,464

15,809

15,744

16,035

17,274

18,123

29,627

13,110

10,492

10,826

11,700

10,788

7,354

7,791

13,362

20,997

20,362

18,864

21,736

17,776

14,330

13,363

11,770

8,691

3,612

4,106

3,095

Lease liability - noncurrent portion

1,363

1,578

647

778

948

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue, net of current portion

-

-

-

-

-

-

-

49,513

49,037

35,139

36,736

38,333

39,931

41,528

43,125

44,722

46,319

47,917

49,514

-

-

-

-

-

1,733

1,933

2,133

2,333

2,533

2,733

2,933

3,133

3,333

3,533

3,733

3,933

-

-

-

Deferred rent - noncurrent portion

-

-

-

-

-

4

6

5

3

1

14

52

89

126

163

200

276

313

379

470

553

570

665

730

792

851

349

365

384

400

415

363

316

180

77

58

44

55

66

Derivative liabilities

-

-

-

-

-

-

2,597

2,358

2,469

2,424

2,350

2,480

2,471

862

694

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Series 1 preferred stock issuance obligation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

119,045

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Warrant liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

247

6,094

11,694

11,776

9,983

-

-

12,962

-

-

-

-

-

-

-

-

-

Other long- term liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

17

-

-

20

20

20

20

20

2,576

2,174

0

21,528

25,472

25,194

19,425

22,584

36,011

27,311

21,085

18,471

Total liabilities

17,942

14,104

11,823

11,178

9,287

9,487

62,786

61,190

61,571

58,420

57,289

56,853

59,955

58,325

59,726

180,002

63,869

66,353

79,520

13,597

11,045

11,396

12,632

17,632

21,593

22,371

25,847

26,271

25,453

34,959

46,612

46,744

43,173

36,501

38,164

48,693

30,967

25,246

21,632

Commitments and contingencies (Note 6)

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Preferred stock, $0.001 par value, 30,000,000 shares authorized

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

-

0

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

Stockholders' equity:
Common stock, $0.001 par value; 250,000,000 shares authorized; 214,286,337 and 181,803,320 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

214

182

181

162

162

161

142

142

142

143

142

142

132

132

132

132

132

132

131

131

128

104

103

101

101

100

84

84

84

83

80

80

80

69

68

68

48

49

42

Additional paid-in capital

882,541

778,953

774,324

656,216

653,817

651,732

604,653

609,247

613,302

615,493

619,232

622,052

578,571

580,567

582,225

583,797

582,400

579,939

576,934

575,364

571,318

406,349

398,585

390,192

388,570

386,511

331,817

330,735

327,495

325,177

305,538

304,219

302,603

246,519

244,670

243,809

131,530

131,284

96,133

Additional paid-in capital - warrants issued

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,541

3,603

3,603

3,657

3,728

6,837

6,909

6,909

7,012

7,079

12,611

13,722

13,797

22,789

22,834

23,073

Accumulated deficit

-702,400

-684,125

-668,379

-594,383

-579,763

-566,329

-761,209

-748,624

-736,593

-712,442

-699,169

-686,468

-673,606

-657,997

-646,773

-635,919

-504,719

-492,700

-483,224

-465,054

-450,843

-372,612

-362,211

-356,118

350,542

-340,831

331,927

315,215

296,523

283,724

253,499

235,675

212,062

187,592

174,348

173,546

123,814

111,963

91,144

Total stockholders' equity

180,337

95,010

106,126

61,995

74,216

85,564

-156,414

-139,235

-123,149

-96,806

-79,795

-64,274

-94,903

-77,298

-64,416

-51,990

77,813

87,371

93,841

110,441

120,603

33,841

36,477

37,716

41,732

49,383

3,631

19,332

37,893

48,445

59,028

75,636

97,700

71,607

84,112

84,128

30,553

42,204

28,104

Total liabilities and stockholders' equity

198,279

109,114

117,949

73,173

83,503

95,051

66,801

76,383

87,461

105,606

116,559

126,813

94,494

106,348

117,122

128,012

141,682

153,724

173,361

124,038

131,648

45,237

49,109

55,348

63,325

71,754

29,478

45,603

63,346

83,404

105,640

122,380

140,873

108,108

122,276

132,821

61,520

67,450

49,736

Series 1 Preferred Stock
Series 1 preferred stock, $1,200 stated value; 250,000 designated; 0 shares issued and outstanding at December 31, 2019 and 2018; liquidation value of $0 million at December 31, 2019 and 2018

-

-

-

-

-

-

-

-

-

143,992

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-